Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer

被引：10
|
作者：
Fagotti, Anna [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
机构：
[1] Fdn Policlin Univ Agostino Gemelli, IRCCS, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 12期
关键词：
OVARIAN-CANCER;
D O I：
10.1016/S1470-2045(18)30625-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1558 / 1560
页数：3
相关论文
共 50 条
  • [1] Advanced ovarian yolk sac tumor: upfront surgery or neoadjuvant chemotherapy followed by interval debulking?
    Zhang, Xinyue
    Yang, Jie
    Xiang, Yang
    Pan, Lingya
    Wu, Ming
    Cao, Dongyan
    Yang, Jiaxin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (01) : 99 - 105
  • [2] Neoadjuvant chemotherapy for advanced ovarian cancer: the tail of the scorpion for radical debulking surgery?
    Fotopoulou, Christina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (11) : 1665 - 1666
  • [3] Clinical Outcome of Iranian Patients with Advanced Ovarian Cancer with Neoadjuvant Chemotherapy versus Primary Debulking Surgery
    Ghaemmaghami, Fatemeh
    Karimi-Zarchi, Mojgan
    Modares-Gilani, Mitra
    Mousavi, Azamsadat
    Behtash, Nadereh
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2008, 9 (04) : 719 - 724
  • [4] The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer
    Rosen, Barry
    Laframboise, Stephane
    Ferguson, Sarah
    Dodge, Jason
    Bernardini, Marcus
    Murphy, Joan
    Segev, Yakir
    Sun, Ping
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (03) : 462 - 467
  • [5] Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
    J. Alejandro Rauh-Hain
    Noah Rodriguez
    Whitfield B. Growdon
    A. K. Goodman
    David M. Boruta
    Neil S. Horowitz
    Marcela G. del Carmen
    John O. Schorge
    Annals of Surgical Oncology, 2012, 19 : 959 - 965
  • [6] Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Propensity-matched Analysis
    Siesto, Gabriele
    Cavina, Raffaele
    Romano, Fabrizio
    Vitobello, Domenico
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (03): : 280 - 285
  • [7] Minimally invasive interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapy
    Jorgensen, Kirsten
    Melamed, Alexander
    Wu, Chi-Fang
    Nitecki, Roni
    Pareja, Rene
    Fagotti, Anna
    Schorge, John O.
    Ramirez, Pedro T.
    -Hain, Jose Alejandro Rauh
    GYNECOLOGIC ONCOLOGY, 2023, 172 : 130 - 137
  • [8] Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Ce Bian
    Kui Yao
    Li Li
    Tao Yi
    Xia Zhao
    Archives of Gynecology and Obstetrics, 2016, 293 : 163 - 168
  • [9] Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Bian, Ce
    Yao, Kui
    Li, Li
    Yi, Tao
    Zhao, Xia
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (01) : 163 - 168
  • [10] Neo-adjuvant Chemotherapy Followed by Interval Debulking Surgery Versus Upfront Surgery Followed by Chemotherapy in Advanced Epithelial Ovarian Carcinoma
    Meleis M.H.
    El-Agwany A.S.
    Indian Journal of Gynecologic Oncology, 2016, 14 (1)
12345